Compare APGE & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | WING |
|---|---|---|
| Founded | 2022 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | 2023 | 2015 |
| Metric | APGE | WING |
|---|---|---|
| Price | $90.54 | $189.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 27 |
| Target Price | $109.67 | ★ $308.42 |
| AVG Volume (30 Days) | 881.1K | ★ 1.3M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.63% |
| EPS Growth | N/A | ★ 67.84 |
| EPS | N/A | ★ 6.21 |
| Revenue | N/A | ★ $696,853,000.00 |
| Revenue This Year | N/A | $17.20 |
| Revenue Next Year | N/A | $15.86 |
| P/E Ratio | ★ N/A | $30.50 |
| Revenue Growth | N/A | ★ 11.35 |
| 52 Week Low | $34.34 | $142.24 |
| 52 Week High | $95.32 | $388.14 |
| Indicator | APGE | WING |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 50.81 |
| Support Level | $73.06 | $142.24 |
| Resistance Level | N/A | $267.86 |
| Average True Range (ATR) | 3.27 | 11.94 |
| MACD | 0.23 | 4.92 |
| Stochastic Oscillator | 64.72 | 76.74 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.